Table 4.
Adjusted Odds Ratio of Poor Glycemic Control (A1c>7%) Related to Type of Oral Diabetes Medication and Patient Characteristics (n=16,524 Observations for 8740 Individuals)
| Odds Ratio | 95% CI | |
|---|---|---|
| Age | ||
| < 35 | 1.81 | [1.16, 2.82] |
| 35–49 | 1.29 | [1.14, 1.46] |
| 50–64 | 1 | |
| ≥ 65 | 0.84 | [0.78, 0.92] |
| Female | 1.00 | [0.92, 1.08] |
| High morbidity | 0.88 | [0.79, 0.97] |
| Coronary artery disease | 1.08 | [0.97, 1.20] |
| Congestive heart failure | 0.91 | [0.77, 1.06] |
| Race/ethnicity | ||
| White | 1 | |
| Japanese | 1.01 | [0.81, 1.26] |
| Chinese | 0.88 | [0.64, 1.21] |
| Filipino | 1.19 | [0.93, 1.51] |
| Native Hawaiian | 1.13 | [0.88, 1.46] |
| Other Pacific Islander | 0.88 | [0.40, 1.69] |
| Other race | 0.75 | [0.51, 1.08] |
| Mixed race | 1.04 | [0.78, 1.39] |
| Race missing | 1.11 | [0.90, 1.37] |
| Year | ||
| 2008 | 1 | |
| 2009 | 0.62 | [0.57, 0.68] |
| 2010 | 0.95 | [0.86, 1.05] |
| Diabetes duration | ||
| 1–2 years | 0.38 | [0.21, 0.66] |
| 3–4 years | 0.74 | [0.66, 0.83] |
| 5–9 years | 0.90 | [0.82, 0.98] |
| 10+ years | 1 | |
| Type of oral medication | ||
| Combination sulfonylureas | 1 | |
| Combination DPP-4 inhibitors | 1.32 | [1.12, 1.57] |
| DPP-4 Inhibitors | 1.54 | [1.38, 1.71] |
| GLP-1 agonists | 1.48 | [1.21, 1.80] |
| Sulfonylureas | 2.07 | [1.92, 2.24] |
| Other oral diabetes medications | 2.56 | [0.96, 6.82] |
| Prior year's A1C level | ||
| < 7% | 1 | |
| 7%–9% | 25.2 | [20.8,30.4] |
| > 9% | 8.6 | [7.9,9.3] |
CI, confidence interval.